Provider-Payer-Pharma
Cross-Industry Data Collaboration

Deploying Information Technology to Sustain Innovation within the Rapidly Changing Care Delivery Models

 

Day 1 | Day 2 | Workshops | Download Brochure 

Monday, April 8

7:00 am Conference Registration and Morning Coffee


» OPENING KEYNOTES AND PANEL 

CONNECTING PATIENTS, PROVIDERS, AND PAYERS 

8:00 Welcome and Chairperson's Remarks

Micah LiebermanMicah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI) and Bio-IT World Expo






8:15 Deploying Information Technology to Enable Innovation within the Future State of Care: Connecting Patients, Providers, and Payers

John HalamkaJohn Halamka, M.D., MS, CIO, Beth Israel Deaconess Medical Center

The 5 year Meaningful Use plan creates an ecosystem for innovation. The speaker will reflect on the latest Federal and State projects that bring data liquidity to payers, providers, patients and third party companies. 2013 is likely to be the tipping point in healthcare IT that ushers in a new era of modular applications and cloud hosted services leveraging the newly freed healthcare data, exchanged with patient consent.


8:40 Making Data Actionable: Driving Better Decision Making by Connecting, Collecting and Comparing Data to Create More Affordable, More Effective Health Care

Lonny ReismanLonny Reisman, M.D., Senior Vice President, CMO, Aetna

Aetna is a technology user and systems enabler in the healthcare services space. The company is also bringing all participants into a clinical analytics environment that can connect rich, continuous clinical data to definable clinical and cost outcomes. Dr. Reisman will describe how Aetna is pushing the boundaries of technology to develop new ways to intelligently process complete clinical and cost data -- including lab, pharmacy, pathology, and outcomes information -- and turn it into usable information. Using structured information and complete analytics facilitates the identification of trends, associations, comparisons of treatments and supports clinical and financial decision making, accountability, and risk sharing. Dr. Reisman will explore how this convergence creates a safer, more effective and efficient health system.

9:05 Preparing for the Tidal Wave: Prepositioning Information Technology Needed to Support Deeper Use of Genetics in the Clinic

Sandy AronsonSandy Aronson, Executive Director, IT, Partners HealthCare Center for Personalized Genetic Medicine

Clinical genetic tests covering large numbers of genes are becoming increasingly common and the first whole genome sequencing tests have begun to enter clinical care. These tests create new and growing challenges for clinicians who need to react to and manage these results over time. Information technology can help. This talk will describe and provide an example of an infrastructure for managing clinical genetic data. Initiatives that could be undertaken now to ensure patients derive the maximum benefit from genetic advances will also be discussed.

 

9:30 Keynote Panel

Major Themes

• Deploying Information Technology to Enable Innovation within the Future State of Care
• Defining, Measuring and Managing Clinical, Operational and Financial Risk
• Provider-Payer-Pharma Collaborations for Patient/Population Care Management

Topics will include

1. What does a connected health care system look like? Can you describe the elements that will need to work together?
2. What are the remaining policy and technology barriers to information sharing?
3. Will ACOs reduce political barriers to data liquidity?
4. How will integrated population health data support collaboration and new, sustainable financial relationships among all players within the health care delivery system?
5. How will patients and families be engaged in accessing, viewing, downloading, and transmitting healthcare data?
6. Is health information technology the missing link needed to make the health care system work better for providers and patients? What more needs to be done?

Panelists:
Sandy Aronson, Executive Director, IT, Partners HealthCare Center for Personalized Genetic Medicine
Mark Davies, M.D., Executive Medical Director, Health & Social Care Information Centre, National Health Service
John Halamka, M.D., MS, CIO, Beth Israel Deaconess Medical Center

Lonny Reisman, M.D., Senior Vice President, CMO, Aetna


10:00 Coffee Break in the Exhibit Hall with Poster Viewing

 

HEALTHCARE IT AND ANALYTICS: VALUE AND RISKS 

10:40 Chairperson's Remarks

Jon Duke, M.D., Research Scientist, Regenstrief Institute, Inc.; Assistant Professor Medicine, Indiana University School of Medicine 

10:50 Value Proposition around HIEs: Who Gets What Value

Jeff RoseJeff Rose, Partner, Rose Healthcare Solutions

Many people think that health information exchange is a valuable thing to do. Yet no one seems to be able to define the value proposition in economic terms, either in aggregate or by type of stakeholder. This presentation assembles all of the available published research on the HIE value proposition and explains who wins and how much. This information is vitally important to every stakeholder who is considering whether to participate or continue participating in a HIE.


SAS11:15 Piloting Bundled Payments - How Advanced Analytics Can Help

Graham HughesGraham Hughes, M.D., CMO, SAS Center for Health Analytics & Insights

Few organizations are prepared to manage effectively in an environment of provider risk sharing and pay for value, whether they are looking to carve out populations for risk sharing or participate in one of the many new reimbursement methodologies being piloted by both commercial payers and CMS. This session will describe the data-driven analytics foundations that early adopters have used to establish gain-sharing agreements for bundled payment contracts, and will conclude with lessons learned.


11:40 Cross-Industry Data Collaboration: Potential Value and Risks to Each Type of Stakeholder, and the Current State of Play

Steve Savas, Partner, Healthcare Technology Practice, McKinsey and Company

We will review the potential value that each of the major stakeholder groups (payer/provider/pharma) can get from data partnerships with the others. We will also review the risks of such collaborations. Then we will discuss the types of deals currently announced in the market and how companies are using this data in their core business. The audience will hear an exhaustive overview of the various rationales for entering into the partnerships from the point of view of the other parties, which will help them form their own partnering strategies.

Recombinant_By_Deloitte12:05 pm Race for Real World Data - Outcomes Data & Analytics: Uses, Approach and Issues

Asif DharAsif Dhar, M.D., Managing Director, Deloitte Health Informatics & CMIO, Deloitte Consulting






Katherina HolzhauserKatherina Holzhauser, Associate Vice President IS Commercialization, Information Systems, Intermountain Healthcare



12:30 Lunch on Your Own

 

DATA INNOVATIONS AND COLLABORATIONS TO IMPROVE OUTCOMES 

1:35 Chairperson's Remarks

Vipul Kashyap, Director, Information Management & Analytics, Cigna Healthcare

1:40 Co-Presentation: Merck-Regenstrief Partnership: Advancing Personalized Delivery of Care through Real World Healthcare Research & Innovation

Patrick LoerchPatrick Loerch, Ph.D., Director, Health Informatics, Merck & Co.







Jon DukeJon Duke, M.D., Research Scientist, Regenstrief Institute, Inc.; Assistant Professor Medicine, Indiana University School of Medicine

The Regenstrief-Merck partnership aims to improve the health of patients through healthcare innovation, data analytics, and research that supports personalized delivery of care. In this talk we will discuss some key lessons learned on the organizational structure and operation of a successful pharmaceutical-academia partnership. With almost a year and the execution of a diverse range of collaboration projects under our belt, we will also review specific research areas where pharmaceutical and academic drivers are well aligned and thus are well suited for partnering.

CliniWorks2:15 Real-World Clinical Data Mining, Driving Cross-Industry Collaboration: Supporting Accelerated Evidence Extraction, Informed Pipeline Decision Making, Clinical Trial Recruitment and Improving Personalized Care

Nitzan SnehNitzan Sneh, CEO, CliniWorks, Inc.

CliniWorks will discuss a comprehensive enterprise clinical data management technology that bridges the gaps between payers, providers and pharmaceutical sponsors. CliniWorks will share insight into the impact of technology using advanced data mining tools with real-world patient data to transform disparate healthcare data into useful, actionable information. The impact is invaluable in helping payers accurately adjudicate their payment systems and ultimately track cost-savings, enabling providers to improve quality metrics, and addressing pharma’s drug development lifecycle from clinical trial design and enrollment through post-approval outcomes analyses.

Cognizant 2:30 Co-Presentation: Semantic Technology for Provider-Payer-Pharma Cross-Industry Data Collaboration Building Intelligent Health Data Integration

Nagaraja Srivatsan, Senior Vice President, Strategy, Healthcare & Life Sciences, Cognizant Technology Solutions

Thomas Kelly, Practice Director, Enterprise Information Management – Life Sciences, Cognizant Technology Solutions
Jay A. Warren, EIM Healthcare Practice Evangelist, Enterprise Information Management, Cognizant 

The integration of pharma, provider, payer, and real-world data will identify new ways in which health data can be combined and analyzed to improve quality of care. Semantic technology can speed integration of health data, while supporting an evolutionary approach to developing and leveraging expertise. This presentation will examine key features of semantic technology that support health data integration objectives.

2:55 Refreshment Break in the Exhibit Hall with Poster Viewing

 

CROSS-INDUSTRY DATA PARTNERSHIPS 

3:35 Introductory Remarks: What Worked, What Challenges Existed and What Are the Future Directions?

Hui Cao, M.D., Ph.D., Senior Director, Personalized Healthcare Informatics, Strategic Programs, R&D Information, AstraZeneca Pharmaceuticals LP

3:50 AstraZeneca/Healthcore Collaboration

Mark Weiner, M.D., Senior Director, RWE Informatics, Strategic Programs, R&D Information, AstraZeneca Pharmaceuticals LP

4:10 FDA Mini-Sentinel

Jeff BrownJeff Brown, Ph.D., Assistant Professor, Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School

Mini-Sentinel is a pilot project to inform and facilitate development of a national active surveillance system for monitoring the safety of FDA-regulated medical products. The Mini-Sentinel project includes 18 data partners with over 125 million covered lives and billions of medical encounters and pharmacy dispensings available for querying. The project adheres to a distributed querying approach that allows data partners to maintain control of their data and its uses. Mini-Sentinel has established the infrastructure and capability to rapidly respond to FDA requests.

4:30 Observational Medical Outcomes Partnership (OMOP)

Christian Reich, M.D., Ph.D., Global Head, Discovery Informatics, AstraZeneca Pharmaceuticals LP


Interactive Discussion/Closing Panel 

4:50 Cross-Industry Data Partnerships Overview: What Worked, What Challenges Existed and What Are the Future Directions?

Moderator: Hui Cao, M.D., Ph.D., Senior Director, Personalized Healthcare Informatics, Strategic Programs, R&D Information, AstraZeneca Pharmaceuticals LP

Panelists: Speakers from the Session


Payers are having a significant impact on pharma companies’ ability to deliver valuable medicines to patients. Companies have started to change the way they discover, develop, and commercialize medicines to address patient and payer needs at every stage of the product lifecycle. Longitudinal, integrated patient information is the key to answering complex questions in R&D and commercialization. In order to access patient data across boundaries, companies and regulators are experimenting with various data collaboration models. This session will examine various cross-industry data partnerships, including the AstraZeneca/Healthcore collaboration, FDA’s Mini-Sentinel and OMOP launched by the Foundation for the NIH. Speakers will share with the audience their key lessons learned, examine what worked and what didn’t and discuss what future directions the industry is taking. 


5:15 Medical Informatics World Welcome Reception in the Exhibit Hall with Poster Viewing

6:15 End of Day


Day 1 | Day 2 | Workshops | Download Brochure 

 

Download 2013 Brochure

2013 Medical Informatics World Conference Brochure 

Premier Sponsors
 Cognizant
 
Recombinant_By_Deloitte 

IBM

SAS 

View All Sponsors 
Official Media Partner
 

View Media Partners 
Add to Outlook